This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Summary of interventions for gastro-oesophageal reflux disease

Authoring team

Summary of Interventions for gastro-oesophageal reflux disease (GORD)

  • manage uninvestigated 'reflux-like' symptoms as uninvestigated dyspepsia
  • if GORD then treat with a full-dose PPI (table 1) for 4 or 8 weeks
  • if symptoms recur after initial treatment, offer a PPI at the lowest dose possible to control symptoms
  • discuss with people how they can manage their own symptoms by using the treatment when they need it
  • offer H2RA therapy if there is an inadequate response to a PPI
  • people who have had dilatation of an oesophageal stricture should remain on long-term full-dose PPI ( table 1) therapy
  • a full-dose PPI (table 2) for 8 weeks should be used to heal severe oesophagitis, taking into account the person's preference and clinical circumstances (for example, underlying health conditions and possible interactions with other drugs)
  • if initial treatment for healing severe oesophagitis fails, consider a high dose of the initial PPI, switching to another full-dose PPI ( table 2) or switching to another high-dose PPI ( table 2), taking into account the person's preference and clinical circumstances (for example, tolerability of the initial PPI, underlying health conditions and possible interactions with other drugs)
  • offer a full-dose PPI ( table 2) long-term as maintenance treatment for people with severe oesophagitis, taking into account the person's preference and clinical circumstances (for example, tolerability of the PPI, underlying health conditions and possible interactions with other drugs)
  • if the person's severe oesophagitis fails to respond to maintenance treatment, carry out a clinical review. Consider switching to another PPI at full dose or high dose ( table 2), taking into account the person's preference and clinical circumstances, and/or seeking specialist advice
  • do not routinely offer endoscopy to diagnose Barrett's oesophagus, but consider it if the person has GORD. Discuss the person's preferences and their individual risk factors (for example, long duration of symptoms, increased frequency of symptoms, previous oesophagitis, previous hiatus hernia, oesophageal stricture or oesophageal ulcers, or male gender)

Table 1: PPI doses

PPI

Full/Standard dose

Low dose (on demand dose)

Double dose

Esomeprazole

20 mg* once a day

Not available

40 mg*** once a day

Lansoprazole

30mg once a day

15mg per day

30 mg** twice a day

Omeprazole

20 mg once a day

10mg* per day

40 mg once a day

Pantoprazole

40 mg once a day

20mg per day

40mg twice a day

Rabeprazole

20mg once a day

10mg per day

20mg twice a day

* lower than the licensed starting dose for esomeprazole in GORD, which is 40 mg, but considered to be dose-equivalent to other PPIs. When undertaking meta-analysis of doserelated effects, NICE classed esomeprazole 20 mg as a full-dose equivalent to omeprazole 20 mg.

**off-label dose for GORD

***40 mg is recommended as a double dose of esomeprazole because the 20-mg dose is considered equivalent to omeprazole 20 mg.

Table 2: PPI doses for severe oesophagitis

PPI

Full/Standard dose

Low dose (on demand dose)

Double dose

Esomeprazole

40 mg* once a day

20mg* once a day

40 mg* twice a day

Lansoprazole

30mg once a day

15mg per day

30 mg** twice a day

Omeprazole

40 mg* once a day

20mg* per day

40 mg* twice a day

Pantoprazole

40 mg once a day

20mg per day

40mg** twice a day

Rabeprazole

20mg once a day

10mg per day

20mg** twice a day

* specifically for severe oesophagitis

** off-label dose for GORD.

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.